Peto's paradox revisited: theoretical evolutionary dynamics of cancer in wild populations
Article first published online: 22 NOV 2012
© 2012 The Authors. Evolutionary Applications published by Blackwell Publishing Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Special Issue: Evolution and Cancer
Volume 6, Issue 1, pages 109–116, January 2013
How to Cite
Roche, B., Sprouffske, K., Hbid, H., Missé, D. and Thomas, F. (2013), Peto's paradox revisited: theoretical evolutionary dynamics of cancer in wild populations. Evolutionary Applications, 6: 109–116. doi: 10.1111/eva.12025
- Issue published online: 21 JAN 2013
- Article first published online: 22 NOV 2012
- Manuscript Accepted: 5 OCT 2012
- Manuscript Received: 20 JUL 2012
- Darwinian Evolution of Cancer Consortium
- 1998. Height, early energy intake, and cancer. Evidence mounts for the relation of energy intake to adult malignancies. BMJ 317:1331–1332.
- 1988. Are cell number and cell proliferation risk factors for cancer? Journal of the National Cancer Institute 80:772–775. , and
- 2011. A continuum model for tumour suppression. Nature 476:163–169. Nature Publishing Group. , , and
- 1975. Mutation selection and the natural history of cancer. Nature 255:197–200.
- 2011. Peto's Paradox: evolution's prescription for cancer prevention. Trends in ecology & evolution 26:175–182. Elsevier Ltd. , and
- 1996. Allometry and simple epidemic models for microparasites. Nature 379:720–722. , and
- 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. Journal of the National Cancer Institute 66:1191–1308. , and
- 2008. Waiting for two mutations: with applications to regulatory sequence evolution and the limits of Darwinian evolution. Genetics 180:1501–1509. , and
- 2003. Mathematical oncology: cancer summed up. Nature 421:321. , and
- 2010. Cancer stem cells: back to Darwin? Seminars in cancer biology 20:65–70. Elsevier Ltd.
- 2012. Clonal evolution in cancer. Nature 481:306–313. , and
- 2000. The hallmarks of cancer. Cell 100:57–70. , and
- 2011. Hallmarks of cancer: the next generation. Cell 144:646–674. Elsevier Inc. , and
- 1999. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents. Carcinogenesis 20:205–214. , , , , , , et al.
- 2011. Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature 479:223–227. Nature Publishing Group. , , , , , , et al.
- 1971. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences USA 68:820–823.
- 2001. Two genetic hits (more or less) to cancer. Nature Reviews Cancer 1:637–641.
- 2003. Cancer selection. Nature Reviews Cancer 3:226–231. , , and
- 2009. Wildlife cancer: a conservation perspective. Nature Reviews Cancer 9:517–526. , and
- 2003. Allometry of human fertility and energy use. Ecology Letters 6:295–300. , and
- 2007. Why don't all whales have cancer? A novel hypothesis resolving Peto's paradox. Integrative and Comparative Biology 47:317–328. , , and
- 2004. Evolutionary dynamics of tumor suppressor gene inactivation. Proceedings of the National Academy of Sciences 101:10635–10638. , , , and
- 1999. Lineage selection and the evolution of multistage carcinogenesis. Proceedings. Biological Sciences/The Royal Society 266:493–498.
- 2003. The population genetics of multistage carcinogenesis. Proc Biol Sci 270:1183–1191.
- 2007. Animal cell differentiation patterns suppress somatic evolution. PLoS computational biology 3:e250. , , and
- 2009. Cancer research meets evolutionary biology. Evolutionary Applications 2:62–70. , , , , and
- 1975. Cancer and ageing in mice and men. British Journal of Cancer 32:411–426. , , , , and
- 2004. Concurrent evolution of resistance and tolerance to pathogens. The American Naturalist 164:E90–E102. , and
- 2012. Natural resistance to cancers: a Darwinian hypothesis to explain Peto's paradox. BMC Cancer 12:387. , , , , , , and
- 2007. Scaling of number, size, and metabolic rate of cells with body size in mammals. Proceedings of the National Academy of Sciences USA 104:4718–4723. , , , , , , and
- 2008. Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan. Aging Cell 7:813–823. , , , , , , et al.
- 2005. On the regulation of populations of mammals, birds, fish, and insects. Science 309:607–610. , , , , and
- 2011. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer prevention research (Philadelphia, Pa.) 4:1135–1144. , , and
- 2011. Exploring the genomes of cancer cells: progress and promise. Science 331:1553–1558.
- 1995. The major evolutionary transitions. Nature 374:227–232. , and
- 2012. Malignancies and high birth weight in human: which cancers could result from antagonistic pleiotropy? Journal of Evolutionary Medicine 1:1–5. , , , , , and
- 1975. The role of DNA repair and somatic mutation in carcinogenesis. Advances in Cancer Research 21:391–425. , and
- 1998. Estimation of mutation frequencies in normal mammalian cells and the development of cancer. Seminars in Cancer Biology 8:407–419.
- 2004. Cancer genes and the pathways they control. Nature Medicine 10:789–799. , and
- 1997. A general model for the origin of allometric scaling laws in biology. Science 276:122–126. , , and